Jane Street
DNA icon

Jane Street’s Ginkgo Bioworks DNA Stock Holding History

Jane Street’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-15,100
Closed -$220K – 11370
2025
Q3 		$220K Buy
+15,100
New +$181K ﹤0.01% 9489
2025
Q2 		– Sell
-17,600
Closed -$100K – 9862
2025
Q1 		$100K Sell
17,600
-14,600
-45% -$149K ﹤0.01% 8805
2024
Q4 		$316K Buy
32,200
+18,000
+127% +$154K ﹤0.01% 7647
2024
Q3 		$116K Buy
14,200
+13,760
+3,127% +$138K ﹤0.01% 8937
2024
Q2 		$5.88K Sell
440
-15
-3% -$448 ﹤0.01% 9152
2024
Q1 		$21.1K Sell
455
-1,008
-69% -$52.2K ﹤0.01% 8894
2023
Q4 		$98.9K Sell
1,463
-367
-20% -$22.5K ﹤0.01% 8584
2023
Q3 		$132K Sell
1,830
-1,008
-36% -$80.6K ﹤0.01% 7845
2023
Q2 		$211K Buy
2,838
+323
+13% +$19.1K ﹤0.01% 7623
2023
Q1 		$134K Sell
2,515
-750
-23% -$47.5K ﹤0.01% 8075
2022
Q4 		$221K Sell
3,265
-5,255
-62% -$483K ﹤0.01% 7522
2022
Q3 		$1.06M Buy
8,520
+4,437
+109% +$529K ﹤0.01% 5306
2022
Q2 		$389K Sell
4,083
-9,647
-70% -$1.18M ﹤0.01% 7174
2022
Q1 		$2.21M Buy
13,730
+3,365
+32% +$655K ﹤0.01% 4566
2021
Q4 		$3.44M Buy
10,365
+4,437
+75% +$2.11M ﹤0.01% 3458
2021
Q3 		$2.75M Buy
+5,928
New +$2.89M ﹤0.01% 3834

Other funds holding DNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
ACG
Anchorage Capital Group New York $436M AUM 38.51% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.18B AUM 27.3% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Jane Street's DNA Position: Q1 2026 in Review

Jane Street sold out of Ginkgo Bioworks (DNA) in Q1 2026, closing a stake of 181,755 shares — an estimated $1.51M sold.

Jane Street first reported a position in DNA in Q3 2021 and held it in 15 quarters. The position peaked at $6.17M in Q4 2023. 174 funds tracked by Wall St. Rank hold DNA as of Q1 2026.

  • Jane Street reported no remaining Ginkgo Bioworks position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 181,755 Ginkgo Bioworks shares in Q1 2026, an estimated $1.51M.
  • Jane Street first reported a position in Ginkgo Bioworks in Q3 2021 and held it in 15 quarters.
  • Jane Street's Ginkgo Bioworks position peaked at $6.17M in Q4 2023.
  • 174 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.